Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Neoplastic Processes
>>
Merck (MSD)
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Zolinza
(vorinostat) / Merck (MSD)
tivantinib
(ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)
tozasertib
(MK-0457) / Merck (MSD)
